Rosaria Lionello
- Molecular Medicine top 10%
- Epidemiology
- Pharmacology
- Infectious Diseases
- Applied Microbiology and Biotechnology top 5%
- Co-authors
- Enrico Maria TrecarichiAlessandro RussoFrancesca SerapideNadia MarascioAndrea BruniEugenio GarofaloFederico LonghiniGiovanni Matera
- Topics
- COVID-19 Clinical Research Studies (4 papers)Antibiotic Resistance in Bacteria (3 papers)Antibiotics Pharmacokinetics and Efficacy (3 papers)
- Journals
- International Journal of Antimicrobial AgentsBMC Infectious DiseasesClinical Chemistry and Laboratory Medicine (CCLM)
- Partner nations
- ItalyBelgiumUnited States
In The Last Decade
Rosaria Lionello
11 papers receiving 148 citations
Peers
Comparison fields: 5 of 47
- Molecular Medicine 62
- Epidemiology 55
- Pharmacology 43
- Infectious Diseases 36
- Applied Microbiology and Biotechnology 34
Countries citing papers authored by Rosaria Lionello
This map shows the geographic impact of Rosaria Lionello's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosaria Lionello with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosaria Lionello more than expected).
Fields of papers citing papers by Rosaria Lionello
This network shows the impact of papers produced by Rosaria Lionello. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosaria Lionello. The network helps show where Rosaria Lionello may publish in the future.
Co-authorship network of co-authors of Rosaria Lionello
This figure shows the co-authorship network connecting the top 25 collaborators of Rosaria Lionello. A scholar is included among the top collaborators of Rosaria Lionello based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosaria Lionello. Rosaria Lionello is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 7 | |
| 2 | 10 | |
| 3 | 15 | |
| 4 | 1 | |
| 5 | 8 | |
| 6 | 27 | |
| 7 | 52 | |
| 8 | 4 | |
| 9 | 11 | |
| 10 | 5 | |
| 11 | 10 |
About Rosaria Lionello
Rosaria Lionello is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Infectious Diseases, having authored 11 papers that have together received 150 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (4 papers), Antibiotic Resistance in Bacteria (3 papers) and Antibiotics Pharmacokinetics and Efficacy (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (34 citations), Molecular Medicine (62 citations) and Endocrinology (14 citations). Rosaria Lionello has collaborated with scholars based in Italy, Belgium and United States. Frequent co-authors include Enrico Maria Trecarichi, Alessandro Russo, Francesca Serapide, Nadia Marascio, Andrea Bruni, Eugenio Garofalo, Federico Longhini, Giovanni Matera, Carlo Torti and Cristian Borrazzo. Their work appears in journals such as International Journal of Antimicrobial Agents, BMC Infectious Diseases and Clinical Chemistry and Laboratory Medicine (CCLM).
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.